The government is putting more money into researching autism because there aren’t a lot of good treatment options, and a study published today seems to underscore the point. The report on a large, NIH-funded trial found the popular antidepressant citalopram doesn’t appear to help kids with autism-spectrum disorders to reduce repetitive behaviors , one of the core characteristics of the condition. Antidepressants like citalopram, part of a class called SSRIs , were thought to help treat autism because they help kids with obsessive-compulsive disorder who also exhibit repetitive behaviors. Citalopram is sold as a generic by several companies and as Celexa by Forest Labs. In this randomized, controlled study, 149 children with autism and related disorders were treated with either citalopram or a placebo for 12 weeks. At the end, there wasn’t any difference between the groups in general functioning or in their repetitive behaviors. About 30% from each group were considered “much improved” at the end of the treatment period.

Read the original:
Study: Drug Doesn’t Reduce Repetitive Behaviors in Autism


Andrew@Protein Supplement



